Oral Factor Xa Inhibitors versus Warfarin for the Treatment of Venous Thromboembolism in Advanced Chronic Kidney Disease

Figure 2

Bar graph of number of patients who had a bleed event, thromboembolic event, and/or discontinued anticoagulation therapy n = 14/48 (29%).